HCM
ZBH icon

Hilton Capital Management’s Zimmer Biomet ZBH Stock Holding History

Hilton Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,109
Closed -$5.95M – 181
2024
Q1 		$5.95M Buy
45,109
+204
+0.5% +$25.5K 0.53% 51
2023
Q4 		$5.46M Sell
44,905
-89
-0.2% -$9.93K 0.59% 49
2023
Q3 		$5.05M Sell
44,994
-2,364
-5% -$300K 0.67% 41
2023
Q2 		$6.9M Sell
47,358
-903
-2% -$123K 0.83% 33
2023
Q1 		$6.15M Sell
48,261
-1,155
-2% -$145K 0.81% 31
2022
Q4 		$5.17M Hold
49,416
– – 0.68% 36
2022
Q3 		$5.17M Sell
49,416
-625
-1% -$68.6K 0.68% 36
2022
Q2 		$5.26M Buy
+50,041
New +$5.94M 0.65% 37

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hilton Capital Management's ZBH Position: Q2 2024 in Review

Hilton Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 45,109 shares — an estimated $5.95M sold.

Hilton Capital Management first reported a position in ZBH in Q2 2022 and held it in 8 quarters. The position peaked at $6.9M in Q2 2023. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Hilton Capital Management reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Hilton Capital Management sold 45,109 Zimmer Biomet shares in Q2 2024, an estimated $5.95M.
  • Hilton Capital Management first reported a position in Zimmer Biomet in Q2 2022 and held it in 8 quarters.
  • Hilton Capital Management's Zimmer Biomet position peaked at $6.9M in Q2 2023.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Hilton Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.